Help us: Donate
Follow us on:
×

Menu

Back

Category: Press Releases

Two mice
Woodland Biosciences, which studies metabolism and cancer, has joined the holdings of Ichor Life Sciences. Ichor intends to use Woodland's expertise and research to increase the specializations of its pharmacological division. The full press release is provided here. LaFayette, N.Y. — Ichor Life Sciences, a premium preclinical contract research organization offering services in discovery through pharmacology,...
Michael and Eric With Logos
Yet another group has formed to advance early-stage biotechnology research. This time, the Forever Healthy Foundation, founded by Michael Greve, has formed a $5 million partnership with the Buck Institute in order to fund rejuvenation biotechnology. The full press release is included here. Forever Healthy and Buck Institute announce partnership to advance translational research in...
Apollo logo
Apollo Health Ventures, a venture capitalist firm focusing on rejuvenation biotechnology, has raised $180 million in order to fund companies developing interventions that target age-related diseases. We have included the full press release below. Apollo Health Ventures Closes $180 Million Fund to Drive Breakthrough Innovations Combating Age-related Diseases BOSTON and BERLIN, December 1, 2021 –...
Press Release
Longevica, a company focused on the biology of aging, has raised $2.5 million dollars for its platform that it hopes will accelerate life extension research. We have included the full press release below. Longevica to Launch an Open Research Platform to Accelerate the Discovery of Life Extension Mechanisms Company raises $2.5M in funding to support...
Live event delivered digitally 28 October 2021 16.00-20.00 CET/07.00-11.00 PST Schlieren, Zürich, Switzerland 14 October 2021 Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, has opened registration for its second “Age Better, Live Longer” Symposium.  The event will be live and delivered digitally. Registration is free. It will be open...
Maximon logo
The venture capitalist firm Maximon has announced a new longevity-focused fund that focuses on financing early-stage biotechnology companies that increase human healthspan. The firm intends to invest 100 million Swiss francs into such companies. The full press release is presented below. Maximon has launched its 100 million Longevity Co-Investment Fund The Longevity Co-Investment Fund finances...
'); }, 2000);